P2RX4 and cancer: In addition, conjugation of anti-P2RX4 Ab with cytotoxic drugs (ADCs) or oligonucleotides (AOCs) can deliver anti-cancer drug payloads [103,104,105], which could selectively and potently target and kill cancer cells that overexpress P2RX4.